The EU regulatory ban on #TitaniumDioxide came into full force in August 2022. RegASK subscribers in the food, pet food, cosmetics, and pharmaceutical industries benefitted from regular updates on this ingredient. Read our blog to learn more. 👉 https://t.co/jMVsuEZTne
Season’s greetings from RegASK!
Our Founder & CEO, Caroline Shleifer, would like to thank everyone for the trust, engagement, and thoughtful exchanges throughout the year. The RegASK team joins Caroline in wishing all a joyful festive season and a successful 2026 ahead.
📢 Regulatory Intelligence Conference Europe 2025 in London has begun!
Explore with Deanna Coscia and Oliver Stein how RegASK AI-driven platform is redefining regulatory intelligence. See you there at Table 2!
A breakthrough in Regulatory Affairs, RegASK introduces the first Agentic AI Command Center, enabling real-time insights, automation, and predictive compliance across 140+ countries.
👉 Read more: https://t.co/yq9j0gWewH
🎉 That’s a wrap on RAPS Convergence 2025!
An incredible 3 days in Pittsburgh connecting with global regulatory leaders and innovators shaping the future of compliance.
Huge thanks to everyone who visited @ASKRegASK Booth #843 and to @RAPSorg for hosting such a meaningful event.
🔍 Global regulators confirm no proven link between paracetamol use in pregnancy and autism. It remains safe and recommended for pain and fever when used as directed.
👉 Full update: https://t.co/NdSxXEsjZp…
📰 In the Media | RegASK is featured in SDCExec for launching its new Agentic AI Architecture, built to help CPG regulatory teams automate workflows, boost accuracy & respond faster to change.
👉 Read more: https://t.co/SbdRt007xP
#RegASK#RegTech#RegulatoryIntelligence#CPG
🚀 RegASK featured in FoodNavigator-USA!
CPTO, Amenallah Reghimi, shares how AI-driven tools help CPG brands turn MAHA compliance into a strategic advantage.
👉 Read more: https://t.co/6Kvbe3OcII
#RegTech#RegulatoryIntelligence#RegASK
🗂️ Pharma & medtech face rising regulatory risks + digital disruption. The solution? AI-driven Regulatory Intelligence.
Discover how RegASK turns compliance into a growth enabler + our decentralized trial success story 🌍👇
https://t.co/18t3kwJV3O
#RegTech#LifeSciences
The Parkinson’s disease therapeutics market is set to hit $7B by 2033 in 7 major markets.
💊 8 late-stage drugs in pipeline
🧠 Disease-modifying therapies advancing
🧬 Cell-based innovation in Phase III
A new era of neurology innovation is here.
https://t.co/uwwsOPuIZl
🚀 RegASK is heading to Reuters Pharma Japan 2025 this September in Tokyo!
With AI-driven regulatory intelligence, RegASK helps pharma:
✅ Accelerate market readiness
✅ Reduce regulatory risks
✅ Free up resources for innovation
📅 Book a slot: https://t.co/kgqTluCNcQ
🌿 Ashwagandha bans? It’s happening.
From Denmark to India, regulators are cracking down on herbal supplements over safety concerns. 📉 Reformulations, recalls & risk alerts are on the rise.
🔗 Full breakdown: https://t.co/dZTDAPvDZ2
#RegASK#HerbalSupplements#Ashwagandha
🚫 EU bans TPO in cosmetics from Sept 1, 2025
📌 TPO (used in nail gels) linked to skin irritation & reproductive toxicity
📌 All TPO products must be removed from market by Aug 31
📌 Strict enforcement across the EU
👉 https://t.co/xGzyauIeGq
🚀 FDA launches the Regulatory Accelerator for digital health innovators (July 24, 2025). Key tools to streamline software-based medical device compliance:
✅ Resource Index
✅ Guidance Navigator (aligned w/ eSTAR)
✅ Early Orientation Meetings
👉 https://t.co/9VY1nxTjA9
Take RegASK’s 2026 State of Regulatory Affairs & Compliance Survey to share your insights on regulatory complexity, trade disruption, compliance gaps, and AI adoption.
Takes 5 mins →
https://t.co/rGScXW4Lnn
#RegASK#RegTech#RegulatoryIntelligence#AiinRegulatoryAffairs